Smoking Cessation Aids in the USA
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins and Dietary Supplements – Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
Table 1 Retail Sales of Homeopathy 1999-2004
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003
3.3 Key Trends and Developments
Table 6 Adults’ First Choice of Action for Common Ailments 2001
3.4 Competitive Environment
Table 7 OTC Healthcare Company Shares 2001-2004
Table 8 OTC Healthcare Brand Shares 2001-2004
3.5 Leading Company Profiles – Bayer Corporation
Summary 2 Bayer AG Operational Indicators 2004
Summary 3 Bayer AG: Production Statistics 2004
Table 9 Bayer Corp Shares of OTC Healthcare by Subsector 2001-2004
3.6 Leading Company Profiles – Bristol-Myers Squibb Co
Summary 4 Bristol-Myers Squibb Co Operational Indicators 2004
Table 10 Bristol-Myers Squibb Co Shares of OTC Healthcare by Subsector 2001-2004
Table 11 Mead Johnson Nutritionals Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles – GlaxoSmithKline Plc
Summary 5 GlaxoSmithKline Plc Operational Indicators 2004
Table 12 GlaxoSmithKline Consumer Health Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles – Johnson & Johnson Inc
Summary 6 Johnson & Johnson Inc Operational Indicators 2004
Table 13 McNeil Consumer & Specialty Pharmaceuticals Shares of OTC Healthcare by Subsector 2001-2004
Table 14 Johnson & Johnson Consumer Products Inc Shares of OTC Healthcare by Subsector 2001-2004
Table 15 Advanced Care Products Shares of OTC Healthcare by Subsector 2001-2004
Table 16 Neutrogena Corp Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Companies – NBTY Inc
Summary 7 NBTY Inc Operational Indicators 2004
Summary 8 NBTY Inc Production Statistics 2004
Table 17 Rexall Sundown Inc Shares of OTC Healthcare by Subsector 2001-2004
Table 18 NBTY Inc Shares of OTC Healthcare by Subsector 2001-2004
3.10 Leading Companies – Novartis AG
Summary 9 Novartis AG Operational Indicators 2004
Summary 10 Novartis AG Production Statistics 2004
Table 19 Novartis Corp Shares of OTC Healthcare by Subsector 2001-2004
Table 20 Ciba Vision Corp Shares of OTC Healthcare by Subsector 2001-2004
Table 21 The Gerber Products Co Shares of OTC Healthcare by Subsector 2001-2004
3.11 Leading Companies – Pfizer Inc
Summary 11 Pfizer Inc Operational Indicators 2004
Summary 12 Pfizer Inc Production Statistics 2004
Table 22 Pfizer Consumer Healthcare Shares of OTC Healthcare by Subsector 2001-2004
3.12 Leading Companies – The Procter & Gamble Company
Summary 13 The Procter & Gamble Company Operational Indicators 2004
Table 23 The Procter & Gamble Co Shares of OTC Healthcare by Subsector 2001-2004
3.13 Leading Companies – Schering-Plough Corp
Summary 14 Schering-Plough Corp Operational Indicators 2004
Summary 15 Schering-Plough Corp Production Statistics 2004
Table 24 Schering-Plough Healthcare Products Inc Shares of OTC Healthcare by Subsector 2001-2004
3.14 Leading Companies – Wyeth
Summary 16 Wyeth Operational Indicators 2004
Summary 17 Wyeth Production Statistics 2004
Table 25 Wyeth Consumer Healthcare Shares of OTC Healthcare by Subsector 2001-2004
3.15 Emerging and Niche Companies
Summary 18 Chattem Inc Operational Indicators 2004
Summary 19 Perrigo Co Operational Indicators 2004
3.16 Retail Distribution
Table 26 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 27 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.17 Retailer Activity and Private Label Trends
Table 28 Penetration of Private Label Products by Sector 2001-2004
3.18 Forecast Market Performance
Table 29 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 30 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
4. SMOKING CESSATION AIDS SALES
4.1 Number of Smokers
Table 31 Number of Smokers by Gender 1999-2004
4.2 Sector Performance
Table 32 Sales of Smoking Cessation Aids by Subsector: Value 1999-2004
Table 33 Sales of Smoking Cessation Aids by Subsector: % Value Growth 1999-2004
Table 34 Smoking Cessation Aids Company Shares 2001-2004
Table 35 Smoking Cessation Aids Brand Shares 2001-2004
Table 36 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 37 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
4.3 New Product Developments
Summary 20 Smoking Cessation Aids: New Product Launches 2003-2004
5. OTHER OTC
6. DEFINITIONS
